secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCA Healthcare, Inc. (HCA)
CIK:        0000860730
Form:       8-K
Filed at:   2024-04-26T23:59:59+00:00
Accession:  0001193125-24-115857
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCA Q1 revenue up 11% to $17.34B, EPS $5.93; reaffirms FY guidance
------------------------------------------------------------------

- Revenue $17.339B (+11.2% YoY); net income $1.591B ($5.93 diluted EPS) vs $1.363B ($4.85).
- Adjusted EBITDA $3.353B; same facility admissions +6.2%, equivalent admissions +5.2%.
- Cash from operations $2.469B; repurchased 3.894M shares for $1.180B; $5.595B remaining.
- Board declared $0.66/share dividend, payable June 28 to holders of record June 14.
- Reaffirmed 2024 guidance; includes $201M gain on sale of California hospital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/860730/000119312524115857/0001193125-24-115857-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/860730/000119312524115857/d799245d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-115857

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer